Acupuncture and Pain Processing
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this study is to test the hypothesis that acupuncture will reduce Fibromyalgia pain, via alterations in the processing of pain in the central nervous system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 14, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedFirst Posted
Study publicly available on registry
January 5, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedMay 23, 2013
May 1, 2013
8 months
April 14, 2010
May 22, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Pain rating to Temporal Summation and Diffuse Noxious Inhibitory Control (DNIC) as measured by a visual analogue scale
Measured at last study acupuncture session (6 weeks post enrollment)
Secondary Outcomes (2)
Change in Fibromyalgia Impact Questionnaire
Change from first to last study treatment session (6 weeks)
Change in Brief Pain Inventory
Change from first to last treatment session (6 weeks)
Study Arms (1)
Acupuncture
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Age 18-50
- Fibromyalgia patient OR healthy control
- No current opioid use
- Patients: must have had Fibromyalgia for 6 months or longer
You may not qualify if:
- Inflammatory disorder (lupus, rheumatoid arthritis)
- Current untreated depression
- Active infection
- Healthy controls: pain disorder or major medical condition that in the discretion of the investigator interfere with the validity of the study
- Heart disease or use of a cardiac pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sean Mackey
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 14, 2010
First Posted
January 5, 2011
Study Start
April 1, 2010
Primary Completion
December 1, 2010
Study Completion
August 1, 2012
Last Updated
May 23, 2013
Record last verified: 2013-05